Biotech · Private company
ParVation Therapeutics, Inc.
Track this companyFree. Adds ParVation Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials22 recruiting or active
Pipeline programs6From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline6
- AbirateronePhase 1 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- daraxonrasibPhase 1 · Pancreatic CancerClinicalTrials.gov · fetched Nov 12, 2026
- DarolutamidePhase 1 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- DB-1310Phase 1 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- SNV1521Phase 1 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- SNV1521Phase 1 · Pancreatic CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- First in Human Study of SNV1521 With a RAS Inhibitor for People With Advanced Pancreatic CancerPHASE1 · RECRUITING · started Sep 1, 2026ClinicalTrials.gov NCT07756281 · fetched Nov 12, 2026
- SNV1521 in Participants With Advanced Solid TumorsPHASE1 · RECRUITING · started Feb 23, 2024ClinicalTrials.gov NCT06220864 · fetched Nov 12, 2026